Vaccines are in Short Supply Modena will Set Up Plant in Canada
The Canadian government and American biotechnology company Moderna announced on the 11th that Modena will set up a plant in Canada to manufacture vaccines for COVID-19 and other respiratory infections.
Industry Canada Minister Francois-Philippe Champagne and Chief Executive Officer of Modena jointly announced that because the production side cannot cope with the surge in global COVID-19 vaccine demand, this factory will be responsible for the messenger. Ribonucleic acid (mRNA) vaccine orders.
Modena wrote in the statement: “The purpose of the cooperation is to provide Canadians with domestically manufactured mRNA vaccines against various respiratory viruses, including COVID-19, seasonal influenza, respiratory syncytial virus (RSV) and potentially other vaccines. ”
Shen Pan pointed out, “If a new virus emerges-the new Zika or Ebola or the coronavirus or the flu-the Canadian government can decide to use part or all of the production line to specifically target a certain virus to protect Canadians. “.
The government did not disclose the amount invested in the project. However, according to Shen Pan, Modena invested “hundreds of millions of dollars” in this high-tech factory.
Canada currently does not have a domestic vaccine manufacturer, so it needs to rely on the vaccines jointly developed by Modena, Pfizer and the German biotech company BioNTech, or the import of other vaccines, so that 38 million people can be vaccinated against the new coronavirus. Virus.
In May, the Canadian government invested nearly 200 million Canadian dollars (about NT$4.4 billion) to expand the vaccine plant of Resilience Biotechnologies, a biotechnology company in Mississauga, Ontario, and designated an additional 2.2 billion Canadian dollars for the development of biological manufacturing. And the life sciences department.
French pharmaceutical giant Sanofi and Canadian biotech company Medicago were among the first companies to receive Canadian funding in the hope that they can develop vaccines and finally make them locally.
Modena Chief Executive Stephane Bancel said that the company’s new equipment can start operation by 2024, and initially it can produce up to 30 million doses of vaccine each year.
He pointed out: “In the past 6 to 9 months, dozens of countries have approached us, hoping that we will build factories there. Among them, Canada is the fastest. We look forward to using similar models to build more factories around the world. .”